PHARMACY

FDA gives Lupin approval, tentative OK for 2 generics
The FDA gave Lupin approval for desvenlafaxine extended-release tablets and tentative approval for tenofovir alafenamide tablets.
Novartis gains FDA nod for Pluvicto
Pluvicto is the first targeted radioligand therapy for treatment of progressive, PSMA-positive metastatic castration-resistant prostate cancer.

Sufficiently similar: What the FDA approval of the first interchangeable biosimilar product means for pharmacists

The approval means that pharmacists will be allowed to switch out Lantus (insulin glargine) for the Semglee (insulin glargine-yfgn) biosimilar without the required approval from the prescribing physician.
Test to treat: Pharmacists nationwide need to have prescriptive authority for COVID-19 antivirals

The program can provide access to lifesaving treatments, and allowing pharmacists to prescribe and dispense will make it more effective and accessible for millions of Americans.
NACDS Annual Meeting Product Box program brings joy, purpose to nonprofit

The NACDS Annual Meeting Product Box program has been a springboard for clients of the Palm Beach Habilitation Center, now The Arc of Palm Beach County, to find employment off-site and in the Palm Beach County community.
Sandoz debuts generic Combigan

Generic Combigan is used to lower eye pressure in patients with ocular hypertension, or high eye pressure.
Amneal obtains FDA nod for Avastin biosimilar

The product, which will be marketed under the proprietary name Alymsys, represents the third bevacizumab biosimilar approval.
Rite Aid reports Q4, full-year results

Growth in the retail pharmacy segment drove a 2.5% and 2.2% hike in Rite Aid's revenues for the quarter and year, respectively.
Alembic rolls out generic Emla cream

Lidocaine and prilocaine cream is indicated as a topical anesthetic for use on normal intact skin for local analgesia.
APhA releases Community Pharmacy Workplace Summit report

The report addresses the drivers impacting workplace and well-being.